Fractal Analytics, Park Medi, and two other companies experienced share price declines as the lock-in period for 3.6 crore shares expired on March 16. The release of these shares marked the start of a potential $72 billion unlock for 88 companies through 2026. The price drops were observed in Fractal Analytics, Aye Finance, Park Medi World, and Nephrocare Health Services following the expiration of their initial public offering (IPO) lock-in periods. The 3.6 crore shares, which were previously restricted from trading, are now available for sale, contributing to the anticipated market impact. The unlock of these shares is part of a broader trend where 88 companies are expected to release shares worth up to $72 billion by 2026. This development has raised concerns among investors about market volatility, as the increased supply of shares could pressure prices in the short term. Analysts noted that the price declines for the affected companies were in line with market reactions to the lock-in expiration. However, the long-term effects of this unlock remain uncertain, as it depends on factors such as investor sentiment, economic conditions, and the performance of the companies involved. The event highlights the significance of lock-in periods in IPOs, which are designed to stabilize share prices during the early stages of a company’s public listing. As these restrictions expire, the market faces a wave of share availability, testing the resilience of investor confidence.#fractal_analytics #nephrocare_health_services #park_medi #aye_finance #lock_in_period
